Advertisement
Screener

C4 Therapeutics, Inc. (CCCC) Auditor

C4 Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, MA, United States.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, MA, United States.
  • 2024-02-22: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, MA, United States.
  • 2023-02-23: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, MA, United States.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31KPMG LLP185Boston, MA, United StatesNo
2025-02-272024-12-31KPMG LLP185Boston, MA, United StatesNo
2024-02-222023-12-31KPMG LLP185Boston, MA, United StatesNo
2023-02-232022-12-31KPMG LLP185Boston, MA, United StatesYes
2022-02-242021-12-31KPMG LLP185Boston, MA, United StatesYes
2021-03-112020-12-31KPMG LLPBoston, MassachusettsNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60